| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034299A1 Method for suppressing multiple drug resistance in cancer cells |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034289A1 Alphavirus vectors for paramyxovirus vaccines |
| 09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |
| 09/13/2000 | EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034207A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 09/13/2000 | EP1034189A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 09/13/2000 | EP1034184A2 Nuclear receptor ligands and ligand binding domains |
| 09/13/2000 | EP1034180A2 Linker nucleoside, and production and use of the same |
| 09/13/2000 | EP1034176A1 Thiophene-sulfonamide compounds |
| 09/13/2000 | EP1034175A1 Substituted phenyloxazolidinones and their use as antibiotics |
| 09/13/2000 | EP1034174A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| 09/13/2000 | EP1034173A2 Method for producing 8-methoxy-quinoline carboxylic acids |
| 09/13/2000 | EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 09/13/2000 | EP1034170A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 09/13/2000 | EP1034167A1 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 09/13/2000 | EP1033997A1 Method of mobilizing hematopoietic stem cells |
| 09/13/2000 | EP1033994A1 Methods of preparation of bioginkgo |
| 09/13/2000 | EP1033992A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 09/13/2000 | EP1033991A1 Mometasone furoate suspensions for nebulization |
| 09/13/2000 | EP1033990A1 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids |
| 09/13/2000 | EP1033989A1 Method for reducing mast cell mediated allergic reactions |
| 09/13/2000 | EP1033988A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 09/13/2000 | EP1033987A2 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 09/13/2000 | EP1033986A1 Formulations comprising dissolved paroxetine |
| 09/13/2000 | EP1033985A1 Stable ascorbic acid preparation for topical use |
| 09/13/2000 | EP1033984A1 Concentrate for medical solution and use thereof |
| 09/13/2000 | EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1033982A1 Agents for combating neospora spec |
| 09/13/2000 | EP1033981A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 09/13/2000 | EP1033980A1 Skin care composition |
| 09/13/2000 | EP1033979A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods |
| 09/13/2000 | EP1033978A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 09/13/2000 | EP1033974A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 09/13/2000 | EP1033973A1 Encapsulation method |
| 09/13/2000 | EP1033971A1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/13/2000 | EP1033970A1 Novel formulation for use in pain management |
| 09/13/2000 | EP1033969A1 Compositions adapted for prolonged residence in the nasal pharynx |
| 09/13/2000 | EP1033962A1 Reduction of hair growth |
| 09/13/2000 | EP1033947A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 09/13/2000 | EP1033913A1 Zwitterionic fatty acid compounds for anti-inflamation |
| 09/13/2000 | EP0983248A4 Analogs of duocarmycin and cc-1065 |
| 09/13/2000 | EP0975617A4 Inhibitors of cholesterol esterase |
| 09/13/2000 | EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/13/2000 | EP0877606B1 Effervescent ibuprofen preparation and process for the production thereof |
| 09/13/2000 | EP0871611B1 New derivatives of glycylanilides, preparation and therapeutical application |
| 09/13/2000 | EP0851761A4 Anti-intoxication composition |
| 09/13/2000 | EP0850050B1 Oral fast-dissolving compositions for dopamine agonists |
| 09/13/2000 | EP0839146B1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 09/13/2000 | EP0817787A4 Nitrogenous macrocyclic compounds |
| 09/13/2000 | EP0806948B1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | EP0763017B1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 09/13/2000 | EP0723439B1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 09/13/2000 | EP0691962B1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance |
| 09/13/2000 | EP0683664B1 Taxol formulation |
| 09/13/2000 | EP0607193B1 Triazole antifungal agents |
| 09/13/2000 | EP0586570B1 Backbone modified oligonucleotide analogues |
| 09/13/2000 | CN1266441A Polymer comprising unsaturated ester units and pharmaceutical and comsetic compositions thereof |
| 09/13/2000 | CN1266438A Method for the continuous production of hydrolytically broken down and possibly substituted starch, use of hydrolytically broken down starch and device for producing same |
| 09/13/2000 | CN1266437A Improved process for antiparasitic agent |
| 09/13/2000 | CN1266435A Process for preparing and purifying 9-nitro-20-camptothecin |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1266433A Benzpyrido cycloheptane compounds useful for inhibition of franesyl protein transferase |
| 09/13/2000 | CN1266432A Bispyrido-cyclohepatne compounds useful for inhibition of farnesyl protein transferase |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266429A Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/13/2000 | CN1266428A Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/13/2000 | CN1266427A New amidino derivatives and their use as thrombin inhibitors |
| 09/13/2000 | CN1266423A 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 09/13/2000 | CN1266421A Anti-cancer compounds |
| 09/13/2000 | CN1266375A Treatment of inflammatory disorders of the bowel and urinary bladder |
| 09/13/2000 | CN1266370A Activated vitamin D3 emulsion-type lotions |
| 09/13/2000 | CN1266369A Dexamethasone gel |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/13/2000 | CN1266061A 2-mercapto-ethylamine cyclized hypocrellin and preparation process and usage thereof |
| 09/13/2000 | CN1266057A Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1266053A Substituted cycloheptaene and its preparation process and use |
| 09/13/2000 | CN1265916A Chinese patent drug for treating peridentitis |
| 09/13/2000 | CN1265911A Medicine for treating cardiovascular disease and preparation process thereof |
| 09/13/2000 | CN1265890A Anti-anaphylaxis nose-drop |
| 09/13/2000 | CN1265889A Medicine for treating epilepsy |
| 09/13/2000 | CN1265888A Medicinal preparations of anti-allergic reaction compound chromonatohydroxypropyl sodium |
| 09/13/2000 | CN1265887A Quick-acting asthma-relieving aerosol and its preparation method |
| 09/13/2000 | CN1265886A Quick-acting powder for giving up smoking |
| 09/13/2000 | CN1265884A Oral nifedipine pill and preparation process |
| 09/13/2000 | CN1265882A Process for preparing medicinal granule |
| 09/13/2000 | CN1056380C Antisense nucleoside for inhibiting growth of human malignant tumor |
| 09/13/2000 | CN1056378C Intermediate for preparing etoposide glucoside and its preparation process |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/13/2000 | CN1056372C Thiazolidinedione derivatives, their production and use |
| 09/13/2000 | CN1056303C Zaohuang ointment for treating burn and preparation process thereof |